Anavex Life Sciences Faces September Board Vote as Blarcamesine Regulatory Strategy Advances

Reported by Yahoo Finance · Published 11 Aug 2026, 11:13 PM MYT (1 d ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Twitch faces backlash over Amazon training AI on its users' livestreams 1 hr ago Bursa slips after opening higher on profit-taking 2 hr ago Asian stocks rise as US inflation data dents Sept Fed hike bets 2 hr ago Oil drops on lower demand forecasts despite deadlock in US-Iran talks 2 hr ago Asian stocks rise as US inflation data dents September Fed hike bets 2 hr ago Ringgit opens higher against major currencies, eases vs US dollar 3 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Anavex Life Sciences Faces September Board Vote as Blarcamesine Regulatory Strategy Advances

Summary

More in Markets

‘The market is obviously on fire’: Should I take $1,000 from my brokerage account to pay off my car loan?

AARP issues urgent call on Medicare drug costs

Cisco sees record results from an AI ‘supercycle,’ but its stock pulls back

Goldman’s latest deal underscores how ‘boomer candy’ ETFs are now big business on Wall Street

Chip stocks are closing in on a bull market. Here’s why some analysts are nervous.

The 10 housing markets where the most sellers have listed their homes for less than what they paid